Zenosense, Inc. (ZENO) – A Healthcare Tech Company on a Mission
Valencia, Spain-based Zenosense is embedded in the emerging healthcare technology arena. Since its establishment in 2008, the company has been focused on developing detection devices. Nowadays, Zenosense is developing functioning, cost-effective medical devices that will identify, very early on, lethal bacteria or cancers in a patient’s expelled breath. The company has its eye on co-developing two key devices with strategic partners; one device is intended to detect lung cancer and the other to detect the Methicillin-resistant Staphylococcus aureus (MRSA) “Super-Bug” in hospitals and clinical settings. Considering that there is less than a 20% chance that lung cancer cases will be…